Opening Remarks from Co-Chairs
Tashica Williams Amirgholizadeh, Ph.D.
Senior Associate General Counsel, IP,
IP Alliance and Due Diligence (IPADD), Team Lead
Gilead Sciences, Inc.
Hilary Libka
Chief IP Counsel, Associate General Counsel
Memorial Sloan-Kettering Cancer Center
Michael Penn
Vice President, IP
BlueRock Therapeutics